FDA Clears BrainsWay Deep TMS™ System for Decreasing Anxiety Symptoms in Depressed Patients - Active Recovery TMS in OR and WA

NOW OFFERING PSYCHOTHERAPY!

We are currently accepting new patients suffering from depression and/or anxiety for psychotherapy services at our NW Portland, Tigard, Clackamas, and Salem locations. Call us at 503.719.4648 to schedule a free consultation or to get more information.

Take our online depression self-assesment

BURLINGTON, Mass. Aug. 18, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) allowing the Company to market its Deep Transcranial Magnetic Stimulation (Deep TMS™) System for the reduction of comorbid anxiety symptoms in adult patients with depression, also known as anxious depression.

“This clearance expands upon BrainsWay’s depression indication, and represents yet another in a series of firsts for the Company,” said Christopher von Jako, Ph.D., President and Chief Executive Officer of BrainsWay. “Many patients suffering from major depression experience anxiety symptoms. This most recent regulatory achievement further establishes BrainsWay’s leadership position at the forefront of bringing transformative solutions to advance patient wellness.”

For more information, visit BrainsWay’s website: https://www.brainsway.com/news_events/fda-clears-brainsway-deep-tms-system-for-decreasing-anxiety-symptoms-in-depressed-patients/

Recent Posts

Different Types of Talk Therapy

Different Types of Talk Therapy

Psychotherapy, also known as talk therapy, is an effective treatment for depression and other mental health conditions. Talk therapy is effective on its own for those with treatment-resistant...

read more
Men & Postpartum Depression (PPD)

Men & Postpartum Depression (PPD)

Postpartum depression (PPD) is often defined as an episode of major depressive disorder (MDD) occurring soon after the birth of a child. It is frequently reported in mothers but can also occur in...

read more

Request a free phone consultation

(We will not share, sell, or spam your email.)